Compugen Ltd (CGEN.OQ)
CGEN.OQ on NASDAQ Stock Exchange Global Market
3.62USD
15 Feb 2019
3.62USD
15 Feb 2019
Change (% chg)
-- (--)
-- (--)
Prev Close
$3.62
$3.62
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
47,228
47,228
52-wk High
$5.00
$5.00
52-wk Low
$2.00
$2.00
About
Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage... (more)
Overall
| Beta: | 0.65 |
| Market Cap(Mil.): | $175.64 |
| Shares Outstanding(Mil.): | 51.13 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CGEN.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 69.44 | 33.70 |
| EPS (TTM): | -0.67 | -- | -- |
| ROI: | -52.36 | 8.92 | 14.45 |
| ROE: | -54.94 | 10.08 | 15.96 |
Bristol-Myers to invest in Compugen, collaborate in clinical trials
TEL AVIV Bristol-Myers Squibb Co and Israel's Compugen said on Thursday they will collaborate in clinical trials for patients with advanced solid tumors.
Bristol-Myers to invest in Compugen, collaborate in clinical trials
TEL AVIV, Oct 11 Bristol-Myers Squibb Co and Israel's Compugen said on Thursday they will collaborate in clinical trials for patients with advanced solid tumours.
Estimates